AstraZeneca is working on COVID-19 vaccine
- By Zhang Rui
0 Comment(s)
Print
E-mail China.org.cn, November 11, 2020
AstraZeneca's ambitious plan in China
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines. Based in Cambridge, U.K., AstraZeneca operates in over 100 countries, and its innovative medicines are used by millions of patients worldwide. The company entered China in 1993 and currently has over 20,000 employees throughout the country. AstraZeneca achieved sales of nearly $4.9 billion in 2019. AstraZeneca's R&D investment in China has reached $1.5 billion, with another investment of more than $1 billion in manufacturing and operation sites.
AstraZeneca has been executing a great plan for China: It has introduced nearly 40 innovative medicines covering respiratory, cardiovascular, metabolic, oncology, gastrointestinal, and renal diseases to China and has built manufacturing sites in Wuxi and Taizhou, both in Jiangsu province, as well as the China Distribution Center in Wuxi.
In 2017, the Healthcare Internet of Things Innovation Center was established in Wuxi to explore innovative IoT-based integrated diagnosis and treatment solutions. In the same year, AstraZeneca cooperated with SDIC Fund in establishing Dizal Pharmaceutical so as to accelerate the local development of innovative medicines. In 2019, AstraZeneca announced that it would co-build Wuxi International Life Science Innovation Campus (I·Campus) with the Wuxi government. It also announced it would be establishing Global R&D (China) and joined hands with CICC Capital to establish the Global Healthcare Industrial Fund.
Lai said he believes the company's future direction is "how we can better take care of patients, and one of our key strategies is to have a deep understanding of the needs of the patient."
"We have a deep understanding of particular disease areas. So, the company's deep knowledge in these areas allows it to go beyond just being a drug company," he said.
Go to Forum >>0 Comment(s)